Publicaciones en colaboración con investigadores/as de Hospital Universitario de Canarias (110)

2024

  1. Management of Colovesical Fistulae: The Updated Evidence

    Current Bladder Dysfunction Reports

2023

  1. Bladder Capacity in Women With Overactive Bladder Syndrome: A Cross-sectional Study

    Urology, Vol. 179, pp. 44-49

  2. Innovative training modality for sacral neuromodulation (SNM): Patient-specific computerized tomography (CT) reconstructed 3D-printed training system: ICS School of Modern Technology novel training modality

    Neurourology and Urodynamics, Vol. 42, Núm. 1, pp. 297-302

  3. Long-Term Functional Outcomes and Quality of Life after Male Transobturator-Retrourethral Sling Surgery

    Urologia Internationalis, Vol. 107, Núm. 3, pp. 304-309

  4. Management of Acute Cystitis in the Era of COVID-19

    Current Bladder Dysfunction Reports, Vol. 18, Núm. 1, pp. 10-15

2022

  1. Artificial Urinary Sphincter in a High-Risk Urethra: Transcorporal Gullwing Modification Description of the Technique

    Turkish Journal of Urology, Vol. 48, Núm. 6, pp. 460-464

  2. BOTULINUM TOXIN, TREATMENT OPTION FOR NEUROGENIC DETRUSOR OVERACTIVITY

    Farmacia, Vol. 70, Núm. 2, pp. 198-203

  3. Current role of neuromodulation in bladder pain syndrome/interstitial cystitis

    Therapeutic Advances in Urology, Vol. 14

  4. Definitions of Urinary Tract Infection Used in Interventional Studies Involving Neurourological Patients—A Systematic Review

    European Urology Focus, Vol. 8, Núm. 5, pp. 1386-1398

  5. Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review

    European Urology Focus, Vol. 8, Núm. 4, pp. 1090-1102

  6. Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  7. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  8. Female Urethroplasty: Anterior Vaginal Wall Flap (Blandy Flap) - Simpler Tends to Be Better

    Urologia Internationalis, Vol. 106, Núm. 3, pp. 313-316

  9. Is the first day of the bladder diary enough for symptom assessment in women with lower urinary tract symptoms?

    Continence, Vol. 2

  10. Recurrent Urinary Tract Infections and Asymptomatic Bacteriuria in Adults

    Current Bladder Dysfunction Reports, Vol. 17, Núm. 1

2021

  1. Corrigendum re “Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex” [Eur Urol Focus 2020;6:522–30] (European Urology Focus (2020) 6(3) (522–530), (S2405456919302962), (10.1016/j.euf.2019.09.020))

    European Urology Focus

  2. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

    Scientific Reports, Vol. 11, Núm. 1

  3. Long-term Outcomes of Sacral Nerve Stimulation in Pelvic Floor Dysfunctions

    International Neurourology Journal, Vol. 25, Núm. 4, pp. 319-326

  4. Same problem, different approaches: Transvesical and extravesical laparoscopic vesicovaginal fistula repair—case report

    Translational Andrology and Urology, Vol. 10, Núm. 10, pp. 3885-3890

2020

  1. Clinical benefit of tamsulosin and the hexanic extract of serenoa repens, in combination or as monotherapy, in patients with moderate/severe luts-bph: A subset analysis of the qualiprost study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14